Perspective Therapeutics, Inc. (CATX)

ASE – Real Time Price. Currency in USD

3.14

-0.04 (-1.10%)

Market open: Aug 12, 2026, 2:03 PM EDT

3.18

+0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

884K

11M

Cost of goods sold

-3M

-2M

-1M

-6M

Gross Profit

-2M

-852K

413K

Operating expenses (excl. COGS)

-101M

-66M

-41M

-12M

Operating Income

-104M

-67M

-41M

-7M

Non-operating income, total

-864K

-14M

835K

119K

Pretax income

-104M

-80M

-40M

-7M

Equity in earnings

Taxes

793K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-104M

-78M

-37M

-7M

Discontinued operations

514K

-949K

-9M

Net income

-103M

-79M

-47M

-7M

Dilution adjustment

Preferred dividends

Perspective Therapeutics, Inc. (CATX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Perspective Therapeutics, Inc. (CATX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Perspective Therapeutics, Inc. (CATX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Perspective Therapeutics, Inc. (CATX)

Income Statement (Annual)

Income Statement (Annual)